Aardvark Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.07

-0.83 (-16.94%)

As of Mar 22, 10:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +544.7% upside

Low Target $21.03

Average Target $26.24

High Target $41.18

Current Price $4.07

Current
$4.07

Target
$26.24

$21.03 $26.24 avg $41.18

Scenario Analysis

Bear Case

$21.03

416.7%

Low target

Base Case

$26.24

+544.7%

Avg target

Bull Case

$41.18

+911.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$17.94

-77.3% from high

52-Week Low

$4.74

+-14.1% from low

Target vs 52W High

$26.24

+46.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%